Comparison of coplanar and noncoplanar intensity-modulated radiation therapy and helical tomotherapy for hepatocellular carcinoma

To compare the differences in dose-volume data among coplanar intensity modulated radiotherapy (IMRT), noncoplanar IMRT, and helical tomotherapy (HT) among patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT). Nine patients with unresectable HCC and PVT underwent step and sh...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Radiation oncology (London, England) England), 2010-05, Vol.5 (1), p.40-40, Article 40
Hauptverfasser:	Hsieh, Chen-Hsi, Liu, Chia-Yuan, Shueng, Pei-Wei, Chong, Ngot-Swan, Chen, Chih-Jen, Chen, Ming-Jen, Lin, Ching-Chung, Wang, Tsang-En, Lin, Shee-Chan, Tai, Hung-Chi, Tien, Hui-Ju, Chen, Kuo-Hsin, Wang, Li-Ying, Hsieh, Yen-Ping, Huang, David Y C, Chen, Yu-Jen
Format:	Artikel
Sprache:	eng
Schlagworte:	Carcinoma, Hepatocellular - pathology Carcinoma, Hepatocellular - radiotherapy Care and treatment Comparative analysis Diagnosis Female Follow-Up Studies Health aspects Hepatoma Humans Liver - radiation effects Lung Neoplasms - pathology Lung Neoplasms - radiotherapy Male Portal Vein - radiation effects Radiotherapy Radiotherapy Dosage Radiotherapy Planning, Computer-Assisted Radiotherapy, Intensity-Modulated Retrospective Studies Survival Rate Thrombosis - pathology Thrombosis - radiotherapy Tomography, Spiral Computed Treatment Outcome Venous thrombosis
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	To compare the differences in dose-volume data among coplanar intensity modulated radiotherapy (IMRT), noncoplanar IMRT, and helical tomotherapy (HT) among patients with hepatocellular carcinoma (HCC) and portal vein thrombosis (PVT). Nine patients with unresectable HCC and PVT underwent step and shoot coplanar IMRT with intent to deliver 46-54 Gy to the tumor and portal vein. The volume of liver received 30Gy was set to keep less than 30% of whole normal liver (V30
ISSN:	1748-717X 1748-717X
DOI:	10.1186/1748-717X-5-40